CompletedNCT01134055
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
PHASE2 · 510 planned enrolment
- Countries listed
- 9
- Registry update
- January 8, 2018
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE2 · 510 planned enrolment
PHASE2 · 19 planned enrolment